Invenra, Astellas sign bispecific antibody discovery agreement

Invenra, Astellas sign bispecific antibody discovery agreement

Source: 
Pharmaceutical Business Review
snippet: 

This collaboration aims to harness Invenra’s B-Body bispecific antibody platform to advance Astellas’ research and development in antibody discovery.